by Juliette Boynton | Jun 1, 2020 | Briefings, EPO
A very rare Appeal Decision by the European Patent Office has recently been issued in which a substantial procedural violation by the Office has been acknowledged meaning that an appeal fee was refunded. This Decision also provides useful guidance on how to...
by Alex Bajjon | May 1, 2020 | Briefings, US & International
Background This case is a preliminary ruling from the Courts of Justice of the European Union (CJEU) following a referral from the German Federal Patent Court regarding Supplementary Protection Certificates. In particular, the referral relates to Article 3(a) of EU...
by David Eyre | Sep 1, 2019 | Briefings, US & International
Eli Lilly is the patent holder of a drug called pemetrexed (Lilly brand “Alimta”) that has been the subject of court proceedings in the UK, which we have reported previously. This case concerns a related issue during US proceedings in which the US Federal...
by Alex Bajjon | May 1, 2019 | Briefings, UK
Background The patent in question (EP 1173181) related to a new dosage regime for tadalafil (marketed under the brand name Cialis®) for treating erectile dysfunction (ED). The patent is owned by ICOS and exclusively licensed to Eli Lilly. The claims of the patent...
by Sean Hughes | Mar 1, 2019 | Briefings, UK
Background The Patent in question related to a method of producing platelet rich plasma (PRP) from whole blood. The inventive concept was said to reside in a resuspension step that allowed preparation of PRP from whole blood using only one centrifugation step. The...
Recent Comments